FDA to evaluate homeopathy regulatory framework

March 24, 2015 6:37 PM

6 0

(Reuters) - The U.S. Food and Drug Administration said it would hold a public hearing seeking information and comment on the use of products labeled 'homeopathic', as well as the agency's regulatory framework for such products.

The hearing, scheduled for April 20-21, will discuss prescription drugs, biological products, and over-the-counter drugs labeled homeopathic, a market that has expanded to become a multimillion dollar industry in the United States.

Also read: Tesla Product Announcement – All Tesla Cars Being Produced Now Have Full Self-Driving Hardware

Read more

To category page